NVIDIA Collaborates With Genentech To Accelerate Drug Discovery Using Generative AI
NVIDIA News, Tuesday, November 21,2023
First-of-its-kind collaboration aims to optimize each company's platform and bring potential medicines to patients faster.
Genentech, a member of the Roche Group, is pioneering the use of generative AI to discover and develop new therapeutics and deliver treatments to patients more efficiently.
A new collaboration between Genentech, the biotechnology pioneer, and NVIDIA aims to transform the discovery and development of new medicines by bringing together experts from each company to optimize and accelerate Genentech's proprietary algorithms.
NVIDIA will work with Genentech to accelerate these models on NVIDIA DGX Cloud, which provides dedicated instances of AI supercomputing and software hosted by NVIDIA cloud service provider partners.